Addus HomeCare (ADUS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Addus HomeCare (ADUS) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Addus HomeCare (ADUS) Beats Q4 Earnings and Revenue Estimates
Addus HomeCare (ADUS) came out with quarterly earnings of $1.77 per share, beating the Zacks Consensus Estimate of $1.71 per share. This compares to earnings of $1.38 per share a year ago.
Ahead of Addus HomeCare (ADUS) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Addus HomeCare (ADUS), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.
ADUS vs. USPH: Which Stock Is the Better Value Option?
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks is more attractive to value investors?
Addus HomeCare (ADUS) Upgraded to Buy: Here's What You Should Know
Addus HomeCare (ADUS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
These 3 Medical Stocks Have Wall Street's Bullish Vote for 2026
COR, ADUS and SEM earn bullish analyst support for 2026 as AI adoption, home care demand and facility expansion fuel medical sector growth.
ADUS or USPH: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks is more attractive to value investors?
Here is Why Growth Investors Should Buy Addus HomeCare (ADUS) Now
Addus HomeCare (ADUS) possesses solid growth attributes, which could help it handily outperform the market.
ADUS vs. USPH: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks offers value investors a better bang for their buck right now?
Addus HomeCare Corporation (ADUS) Presents at UBS Global Healthcare Conference 2025 Transcript
Addus HomeCare Corporation ( ADUS ) UBS Global Healthcare Conference 2025 November 12, 2025 10:15 AM EST Company Participants R. Allison - CEO & Chairman of the Board Brian Poff - CFO, Executive VP, Secretary & Treasurer Heather Dixon - President & COO Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Presentation Albert Rice UBS Investment Bank, Research Division I think we'll get going with our next presenter here, Addus Healthcare -- or Home care, rather, very pleased to have them participating in our conference this year.
Addus HomeCare Corporation (ADUS) Q3 2025 Earnings Call Transcript
Addus HomeCare Corporation ( ADUS ) Q3 2025 Earnings Call November 4, 2025 9:00 AM EST Company Participants R. Allison - CEO & Chairman of the Board Brian Poff - CFO, Executive VP, Secretary & Treasurer Heather Dixon - President & COO Conference Call Participants Dru Anderson - Corporate Communications, Inc. Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Brian Tanquilut - Jefferies LLC, Research Division Joanna Gajuk - BofA Securities, Research Division Albert Rice - UBS Investment Bank, Research Division Jared Haase - William Blair & Company L.L.C.
Addus HomeCare: Decent Print, Weak Economics, Stay On Hold
Q2 revenue was $349.4m, up 21.8% YoY, with adjusted EBITDA of $43.9m and operating cash flow of $22.5m. The business continues to acquire growth and has committed $1.20 in M&A per $1 of new sales over the last 3 years. Returns on capital remain low at ~8–9%, with fair value estimated at $80–$90/share.
